FindTrial
Sign In

The Effect of Short-term Psychodynamic Psychotherapy in Improvement of Intrapsychic Conflicts, Acceptance and Adjustment with Diabetes, Adherence to Treatment and Level of Glycated Hemoglobin (HBA1c): A Randomized Controlled Trial

The Effect of Short-term Psychodynamic Psychotherapy in Improvement of Intrapsychic Conflicts, Acceptance and Adjustment with Diabetes, Adherence to Treatment and Level of Glycated Hemoglobin (HBA1c): A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240317061321N1
Enrollment
40
Registered
2024-05-02
Start date
2024-06-14
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 1 Diabetes. Diabetes mellitus due to underlying condition

Interventions

Intervention 1: Receive Intensive Short-Term Dynamic Psychotherapy intervention. Intervention 2: Control group: They do not receive any intervention.

Sponsors

The University of Semnan
Lead Sponsor

Eligibility

Sex/Gender
All
Age
13 Years to 19 Years

Inclusion criteria

Inclusion criteria: Suffering from type 1 diabetes Membership in Iranian Diabetes Society Desire to participate in research

Exclusion criteria

Exclusion criteria: Suffering from other chronic diseases Taking psychiatric medications Experience of participating in similar researches

Design outcomes

Primary

MeasureTime frame
Intrapsychic Conflicts. Timepoint: The beginning of the study (before the start of the intervention) and the end of the study (after receiving short-term psychodynamic therapy). Method of measurement: Questionnaire of Intrapsychic conflicts (2008).;Acceptance of diabetes. Timepoint: The beginning of the study (before the start of the intervention) and the end of the study (after receiving short-term psychodynamic therapy). Method of measurement: The Persian version of Smith et al.'s Diabetes Acceptance Questionnaire (2022).;Adherence to treatment. Timepoint: The beginning of the study (before the start of the intervention) and the end of the study (after receiving short-term psychodynamic therapy). Method of measurement: Adherence to treatment questionnaire by Morisky et al. (1992).;Adjustment with Diabetes. Timepoint: The beginning of the study (before the start of the intervention) and the end of the study (after receiving short-term psychodynamic therapy). Method of measurement: Adjustment with Diabetes questionnaire by Ebrahimi et al. (2016).;Level of Glycosylated Hemoglobin (HBA1c). Timepoint: The beginning of the study (before the start of the intervention) and the end of the study (after receiving short-term psychodynamic therapy). Method of measurement: HBA1c blood test.—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Eisazadeh

The University of Semnan

f.eisazadeh74@semnan.ac.ir+98 21 4445 1189

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026